| Detected | Trial | Change |
|---|---|---|
| 2026-08-01 | NCT06607302 Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation… |
Trial sites expanded: 13 -> 16 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT05326308 | Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic… | Waldenström's Macroglobulinemia | Recruiting |
| NCT06743035 | Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic… | Polycythemia Vera | Recruiting |
| NCT07240662 | Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma | Glioma | Recruiting |
| NCT04290806 | Registry Platform Gastric/Esophageal Cancer (SAPHIR) | Esophageal Squamous Cell Carcinoma | Recruiting |
| NCT05129969 | Registry Platform Ovarian and Endometrial Cancer | Ovarian Cancer | Recruiting |
| NCT06787105 | Fruquintinib in Patients With Metastatic Colorectal Cancer | Metastatic Colorectal Cancer (mCRC) | Recruiting |
| NCT04510740 | Liver Cancer Registry Platform | Hepatocellular Carcinoma (HCC) | Recruiting |
| NCT03417115 | Breast Cancer Registry Platform | Breast Cancer | Recruiting |
| NCT06976918 | Research Platform Myelofibrosis and Anemia | Primary Myelofibrosis | Recruiting |
| NCT07563595 | Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast… | Breast Cancer | Recruiting |
| NCT07559799 | A Non-interventional Study of Melphalan Flufenamide (Melflufen) (Pepaxti®) and… | Multiple Myeloma | Recruiting |
| NCT03308474 | Myeloma Registry Platform (MYRIAM) | Multiple Myeloma | Recruiting |
| NCT06043011 | Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry… | Chronic Lymphocytic Leukemia (CLL) | Recruiting |
| NCT03374267 | Registry Platform Urologic Cancer | Renal Cell Carcinoma | Recruiting |
| NCT06607302 | Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation… | Cholangiocarcinoma | Recruiting |
| NCT05954780 | Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma | Multiple Myeloma | Active, Not Recruiting |
| NCT04867525 | Registry Platform Colorectal Cancer | Colorectal Cancer Metastatic | Active, Not Recruiting |